GO:0004958 prostaglandin F receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004958 (prostaglandin F receptor activity) is the molecular function of the FP receptor (PTGFR), which binds prostaglandin F2alpha (PGF2alpha) to initiate intracellular signaling.
• The human FP receptor is a class A G protein-coupled receptor whose high-resolution structures reveal the basis of ligand recognition and G protein selectivity.
• FP receptor activation triggers calcium mobilization and downstream calcineurin-NFAT signaling, regulating gene expression in reproductive and cancer cells.
• PGF2alpha can also evoke vascular effects independently of the FP receptor, indicating additional receptor pathways.
• FP receptor activity is implicated in myometrial contraction, inflammatory responses, and endometrial adenocarcinoma progression.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are essential to dissect FP receptor function in disease.
Description
Prostaglandin F receptor activity (GO:0004958) is a molecular function defined as combining with prostaglandin F2alpha (PGF2alpha) to initiate a change in cell activity. This activity is mediated primarily by the FP receptor (gene PTGFR), a G protein-coupled receptor that plays critical roles in reproductive biology, vascular tone, and inflammation. The receptor is a key target for understanding how lipid mediators control cell behavior in both health and disease. Researchers study GO:0004958 to uncover how PGF2alpha signals through the FP receptor to regulate calcium flux, gene transcription, and cellular contraction. The recent determination of human FP receptor structures has provided mechanistic insight into ligand binding and G protein coupling, accelerating drug discovery efforts. Beyond the canonical FP receptor, PGF2alpha can exert effects independent of this receptor, highlighting the complexity of prostanoid signaling. This article synthesizes current knowledge on the genes, mechanisms, and experimental models relevant to prostaglandin F receptor activity.
prostaglandin F receptor activity At A Glance
| GO ID | GO:0004958 |
|---|---|
| GO term | prostaglandin F receptor activity |
| Ontology | molecular_function |
| Synonym | PGF(2-alpha) receptor activity, PGF receptor activity |
| Major function | Binding of prostaglandin F2alpha to initiate intracellular signaling |
| Primary receptor | FP receptor (PTGFR) |
| Ligand | Prostaglandin F2alpha (PGF2alpha) |
| Signaling pathway | G protein-coupled receptor signaling, calcium mobilization |
What Is GO:0004958?
In simple terms, prostaglandin F receptor activity is the ability of a cell to detect and respond to prostaglandin F2alpha. According to the QuickGO definition, it is the function of combining with prostaglandin F2alpha to initiate a change in cell activity. This activity is typically executed by the FP receptor, a cell surface protein that binds PGF2alpha and transmits signals inside the cell.
Why Is prostaglandin F receptor activity Important in Cell Biology?
Prostaglandin F receptor activity is central to diverse physiological and pathological processes, including smooth muscle contraction, ocular pressure regulation, and cancer progression. The FP receptor is a validated drug target for glaucoma and reproductive disorders, and its role in endometrial adenocarcinoma highlights its oncogenic potential. Understanding this activity at the molecular level is essential for developing selective therapeutics and for interpreting how PGF2alpha exerts both receptor-dependent and independent effects.
• Regulates myometrial contraction and inflammatory responses in human pregnancy.
• Drives calcium-calcineurin-NFAT signaling in endometrial adenocarcinoma cells.
• Mediates ATP-induced mechanical allodynia in sensory neurons.
• Involved in ocular hypotension and is a target for glaucoma therapy.
• Stimulates cyclooxygenase-2 promoter activity via the FP receptor.
• Exerts vasoconstrictor and vasodepressor activities, some independent of the FP receptor.
• Provides a structural template for designing selective FP receptor ligands.
• Plays a role in skin physiology and inflammation.
Molecular Mechanism of prostaglandin F receptor activity
Ligand Binding and Receptor Activation
In simple terms: PGF2alpha binds to the FP receptor like a key in a lock, switching the receptor on.
The FP receptor (PTGFR) is a class A G protein-coupled receptor that specifically recognizes prostaglandin F2alpha. Structural studies of the human FP receptor have revealed the ligand-binding pocket and the conformational changes that occur upon agonist binding, which enable G protein coupling. This binding event is the first step in initiating a change in cell activity, as defined by GO:0004958.
G Protein Coupling and Selectivity
In simple terms: Once activated, the receptor talks to G proteins inside the cell to pass on the signal.
The human FP receptor exhibits selectivity for specific G protein subtypes, which determines downstream signaling pathways. Structural analysis has identified key residues that mediate G protein selectivity, providing a mechanistic basis for how FP receptor activation leads to diverse cellular responses.
Calcium Mobilization and Calcineurin-NFAT Pathway
In simple terms: The signal triggers calcium release, which activates a transcription factor called NFAT.
In endometrial adenocarcinoma cells, FP receptor activation by PGF2alpha leads to calcium mobilization and activation of the calcium-calcineurin-NFAT pathway, which regulates the expression of target genes such as CXCL8. This pathway is a critical mediator of FP receptor-driven gene expression.
Receptor-Independent Effects of PGF2alpha
In simple terms: PGF2alpha can also cause effects without using the FP receptor.
Studies have shown that PGF2alpha can evoke vasoconstrictor and vasodepressor activities that are independent of the F prostanoid receptor, suggesting the existence of additional receptors or mechanisms. This highlights the complexity of PGF2alpha biology beyond GO:0004958.
Regulation of Cyclooxygenase-2 Promoter Activity
In simple terms: FP receptor activation can increase the production of inflammatory enzymes.
Stimulation of the FP(B) prostanoid receptor by PGF2alpha enhances cyclooxygenase-2 promoter activity, linking FP receptor signaling to inflammatory pathways. This regulation may contribute to the role of FP receptors in inflammation and cancer.
Key Genes Involved in GO:0004958 prostaglandin F receptor activity
The following genes and proteins are directly involved in prostaglandin F receptor activity and its downstream signaling.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTGFR | Encodes the FP receptor, the primary receptor for PGF2alpha | Target for knockout and structural studies |
| PTGS2 | Cyclooxygenase-2, involved in prostaglandin synthesis | Regulated by FP receptor activation |
| CXCL8 | Chemokine involved in inflammation and cancer | Upregulated via FP receptor-calcium-NFAT pathway |
| NFATC1 | Transcription factor activated by calcium-calcineurin | Mediates FP receptor-induced gene expression |
| GNAQ | G protein alpha q subunit, couples to FP receptor | Potential mediator of FP receptor signaling |
| GNA11 | G protein alpha 11 subunit | May contribute to FP receptor signaling |
| OXTR | Oxytocin receptor, interacts with FP receptor pathways | Modulated by FP receptor antagonists |
| P2RX3 | ATP-gated ion channel involved in allodynia | Linked to FP receptor in mechanical allodynia |
| CALCA | Calcitonin-related polypeptide, pain mediator | Potential downstream of FP receptor in sensory neurons |
| PTGES | Prostaglandin E synthase, related to prostanoid synthesis | Indirectly related to PGF2alpha production |
| PTGS1 | Cyclooxygenase-1, constitutive prostaglandin synthesis | Provides substrate for PGF2alpha |
| AKR1C3 | Aldo-keto reductase, may produce PGF2alpha | Potential source of ligand |
| CBR1 | Carbonyl reductase 1, involved in prostaglandin metabolism | Regulates PGF2alpha levels |
| SLCO2A1 | Prostaglandin transporter | Controls extracellular PGF2alpha availability |
| HPGD | 15-hydroxyprostaglandin dehydrogenase, degrades prostaglandins | Limits PGF2alpha signaling |
| ABCC4 | Multidrug resistance protein 4, prostaglandin efflux | Affects PGF2alpha export |
| PTGFRN | Prostaglandin F2 receptor negative regulator | Modulates FP receptor function |
How Is prostaglandin F receptor activity Regulated?
Prostaglandin F receptor activity is regulated at multiple levels. Receptor expression can be modulated by hormones and inflammatory mediators, and the availability of PGF2alpha is controlled by synthesis and degradation enzymes. Additionally, oxytocin receptor antagonists such as atosiban and nolasiban inhibit PGF2alpha-induced contractions and inflammatory responses in human myometrium, indicating crosstalk between oxytocin and FP receptor pathways. The calcium-calcineurin-NFAT pathway downstream of FP receptor activation is also subject to feedback regulation.
prostaglandin F receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTGFR | Endometrial adenocarcinoma | PTGFR knockout cancer cell lines |
| PTGFR | Preterm labor | Myometrial cell models with FP receptor antagonists |
| PTGFR | Mechanical allodynia | PTGFR knockout mice |
| PTGFR | Glaucoma | Ocular cell lines and animal models |
| PTGS2 | Inflammation | PTGS2 reporter assays with FP receptor agonists |
Endometrial Adenocarcinoma
FP receptor activation by PGF2alpha regulates CXCL8 expression via the calcium-calcineurin-NFAT pathway in endometrial adenocarcinoma cells, promoting an inflammatory tumor microenvironment. This suggests that FP receptor activity contributes to cancer progression and could be a therapeutic target.
Reproductive Disorders
PGF2alpha-induced contractions and inflammatory responses in human myometrium are inhibited by oxytocin receptor antagonists, linking FP receptor activity to preterm labor and other reproductive conditions. Targeting FP receptor signaling may help manage uterine contractility disorders.
Pain and Neuroinflammation
The FP receptor is involved in ATP-induced mechanical allodynia, a type of pain hypersensitivity, indicating a role in sensory neuron signaling. This positions FP receptor activity as a potential target for pain management.
Ocular Hypertension and Glaucoma
Ocular hypotensive prostanoids, including PGF2alpha analogs, lower intraocular pressure through FP receptor activation, making this activity a key target for glaucoma therapy.
From prostaglandin F receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PTGFR mediate PGF2alpha-induced calcium signaling? | PTGFR knockout cell line (e.g., HEK293) |
| What is the structural basis of ligand selectivity? | Point mutations in PTGFR ligand-binding pocket |
| How does FP receptor activation regulate CXCL8? | Knock-in of NFAT reporter in endometrial cancer cells |
| Can FP receptor signaling be modulated by antagonists? | Overexpression of PTGFR in myometrial cells |
| What are the downstream targets of FP receptor in pain? | Tagged knock-in of PTGFR in sensory neurons |
| Does FP receptor activation affect cyclooxygenase-2 promoter? | PTGFR overexpression with COX-2 promoter reporter |
How to Study the prostaglandin F receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium imaging | Intracellular calcium levels | FP receptor activation in live cells |
| Luciferase reporter assay | Transcriptional activity of NFAT or COX-2 | FP receptor signaling to gene expression |
| Cryo-EM | Receptor structure and ligand binding | Mechanistic studies of FP receptor |
| CRISPR knockout | Loss of FP receptor function | Target validation in disease models |
| Site-directed mutagenesis | Effect of point mutations on receptor function | Structure-function analysis |
| RNA-seq | Global gene expression changes | Downstream pathways of FP receptor |
| Western blot | Protein expression and phosphorylation | FP receptor and signaling intermediates |
| Immunohistochemistry | Tissue localization of FP receptor | Clinical correlation studies |
Calcium Mobilization Assays
Measuring intracellular calcium flux using fluorescent dyes or genetically encoded indicators is a standard method to assess FP receptor activation by PGF2alpha.
Luciferase Reporter Assays
Promoter-reporter constructs for NFAT or cyclooxygenase-2 can be used to quantify FP receptor-mediated transcriptional activity.
Structural Biology
Cryo-electron microscopy and X-ray crystallography of the human FP receptor provide atomic-level insights into ligand binding and G protein coupling.
CRISPR-Cas9 Genome Editing
Knockout, point mutation, and knock-in models generated by CRISPR enable precise dissection of FP receptor function in cells and animals.
How CRISPR Can Be Used to Study GO:0004958 prostaglandin F receptor activity
Knockout
CRISPR-Cas9 knockout of PTGFR eliminates FP receptor activity, allowing researchers to test whether observed effects of PGF2alpha are receptor-dependent. This is critical for distinguishing FP receptor-mediated signaling from receptor-independent effects.
Point Mutation
Introducing point mutations in the ligand-binding pocket or G protein coupling domains of PTGFR can reveal residues essential for PGF2alpha binding and selectivity, as guided by structural studies.
Knock-in
Knock-in of reporter genes (e.g., luciferase or fluorescent proteins) into the PTGFR locus enables real-time monitoring of receptor expression and signaling in vivo.
Overexpression
Overexpression of PTGFR in cell lines that normally lack it can reconstitute PGF2alpha responsiveness and facilitate drug screening for FP receptor agonists or antagonists.
How EDITGENE Supports prostaglandin F receptor activity Research
Researchers studying prostaglandin F receptor activity-related genes often need to determine whether a candidate gene is causally involved in PGF2alpha signaling, and CRISPR-based models provide the most direct approach. EDITGENE offers a comprehensive suite of services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for prostaglandin F receptor activity research.
Frequently Asked Questions About prostaglandin F receptor activity
What is prostaglandin F receptor activity?
Prostaglandin F receptor activity (GO:0004958) is the molecular function of binding prostaglandin F2alpha to initiate a change in cell activity, primarily mediated by the FP receptor.
What genes are involved in prostaglandin F receptor activity?
The primary gene is PTGFR, which encodes the FP receptor. Other related genes include PTGS2, CXCL8, and NFATC1.
What is the role of PTGFR in disease?
PTGFR is implicated in endometrial adenocarcinoma, preterm labor, mechanical allodynia, and glaucoma.
How is prostaglandin F receptor activity regulated?
It is regulated by ligand availability, receptor expression, and crosstalk with other receptors such as the oxytocin receptor.
What experimental models are used to study prostaglandin F receptor activity?
Common models include PTGFR knockout cell lines, point mutant receptors, and overexpression systems, often generated by CRISPR.
What is the structure of the FP receptor?
The human FP receptor is a class A G protein-coupled receptor with a ligand-binding pocket that recognizes PGF2alpha and couples to specific G proteins.
Can PGF2alpha act independently of the FP receptor?
Yes, studies show that PGF2alpha can evoke vasoconstrictor and vasodepressor activities independent of the F prostanoid receptor.
What signaling pathways are downstream of FP receptor activation?
FP receptor activation triggers calcium mobilization and the calcineurin-NFAT pathway, leading to gene expression changes.
How can CRISPR help study prostaglandin F receptor activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow precise manipulation of PTGFR and related genes to dissect signaling mechanisms.
What diseases are associated with prostaglandin F receptor activity?
Diseases include endometrial cancer, reproductive disorders, pain hypersensitivity, and glaucoma.
Conclusion
Prostaglandin F receptor activity (GO:0004958) is a fundamental molecular function with broad implications in reproductive biology, cancer, pain, and ocular physiology. The FP receptor (PTGFR) is the primary mediator, and its structural and signaling mechanisms are increasingly well understood. CRISPR-based models are indispensable for causally linking this activity to disease phenotypes. Continued research will likely uncover new therapeutic opportunities targeting this pathway.
References
- 1. Lv X et al.. 2023. Structures of human prostaglandin F(2α) receptor reveal the mechanism of ligand and G protein selectivity.. Nat Commun 14(1):8136 PMID: 38065938
- 2. Zeng R et al.. 2022. Prostaglandin F(2α) evokes vasoconstrictor and vasodepressor activities that are both independent of the F prostanoid receptor.. FASEB J 36(5):e22293 PMID: 35349198
- 3. Kim SH et al.. 2019. Oxytocin Receptor Antagonists, Atosiban and Nolasiban, Inhibit Prostaglandin F(2α)-induced Contractions and Inflammatory Responses in Human Myometrium.. Sci Rep 9(1):5792 PMID: 30962532
- 4. Greaves MW. 1976. Physiology of skin.. J Invest Dermatol 67(1):66-9 PMID: 778297
- 5. Sales KJ et al.. 2009. Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway.. Biochim Biophys Acta 1793(12):1917-28 PMID: 19819266
- 6. Kunori S et al.. 2009. Involvement of prostaglandin F 2 alpha receptor in ATP-induced mechanical allodynia.. Neuroscience 163(1):362-71 PMID: 19490931
- 7. Resul B et al.. 1997. Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids.. Surv Ophthalmol 41 Suppl 2:S47-52 PMID: 9154276
- 8. Fujino H et al.. 2003. Prostaglandin F(2alpha) stimulation of cyclooxygenase-2 promoter activity by the FP(B) prostanoid receptor.. Eur J Pharmacol 465(1-2):39-41 PMID: 12650831
